GlassScriptPhysician profile
Richard A Stennett
NPI 1982686952
$1,914.20
in general payments reported to CMS, 2019-2025
17 companies · $517 in 2025
The $517 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $119 · 2021: $257 · 2022: $335 · 2023: $347 · 2024: $163 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $300.27 | 2019-2023 | Cleviprex |
| Merck Sharp & Dohme LLC | $293.85 | 2019-2025 | Bridion |
| Medtronic, INC. | $286.96 | 2023-2025 | Corevalve Evolut R, Invos |
| Edwards Lifesciences Corporation | $257.94 | 2019-2025 | Sapien 3 Ultra Resilia, Hemosphere |
| Haemonetics Corporation | $213.81 | 2022-2024 | Teg6s Hemostasis System |
| Abiomed | $191.59 | 2022-2023 | Impella |
| Artivion, INC. | $114.28 | 2025 | Cryovalve Sg Pulmonary Human Heart Valve, Cardiac Non-Synergraft, Amds-Ascyrus Medical |
| Baxter Healthcare | $49.80 | 2020-2022 | |
| Heron Therapeutics, INC. | $41.71 | 2019 | |
| Getinge USA Sales, LLC | $29.72 | 2024 | Vasoview Hemopro 2 |
| Fisher & Paykel Healthcare INC | $29.31 | 2023 | Fisher & Paykel Healthcare |
| Csl Behring | $25.21 | 2022 | |
| Ambu INC. | $22.13 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.61 | 2025 | Exparel |
| Mallinckrodt Hospital Products INC. | $15.09 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $14.03 | 2025 | |
| Mallinckrodt Enterprises LLC | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Stennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.